Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022

SELL
$0.42 - $1.48 $41,204 - $145,198
-98,107 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.06 - $2.68 $277,046 - $700,458
-261,365 Reduced 72.71%
98,107 $113,000
Q4 2021

Feb 11, 2022

BUY
$2.5 - $5.19 $898,680 - $1.87 Million
359,472 New
359,472 $899,000
Q3 2021

Nov 15, 2021

SELL
$4.82 - $8.46 $177,559 - $311,649
-36,838 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.81 - $9.71 $140,837 - $200,812
20,681 Added 128.0%
36,838 $306,000
Q1 2021

May 17, 2021

SELL
$7.45 - $12.32 $150,825 - $249,418
-20,245 Reduced 55.62%
16,157 $141,000
Q4 2020

Feb 16, 2021

BUY
$10.34 - $13.77 $228,348 - $304,096
22,084 Added 154.24%
36,402 $395,000
Q3 2020

Nov 16, 2020

SELL
$11.73 - $16.25 $156,548 - $216,872
-13,346 Reduced 48.24%
14,318 $171,000
Q2 2020

Aug 14, 2020

BUY
$13.68 - $20.46 $378,443 - $566,005
27,664 New
27,664 $444,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.